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Cell communication affects all aspects of cell structure and behavior, such as cell proliferation, differentiation, division, and 
coordination of various physiological functions. The moving RNA in plants and mammalian cells indicates that nucleic acid 
could be one of the various types of messengers for cell communication. The microvesicle is a critical pathway that mediates 
RNA moving and keeps moving RNA stable in body fluids. When moving miRNA enters the target cell, it functions by 
altering the gene expression profile and significantly inhibiting mRNA translation in recipient cells. Thus, moving RNA may 
act as a long-range modulator during development, organogenesis, and tumor metastasis. 
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Cell communication is a prerequisite for development and 
differentiation in multicellular organisms, which is mediated 
by a complex network including direct contact, soluble 
factors and gap junction [1,2]. The direct interaction of 
membrane-bound receptors and their cognate ligands can 
initiate the downstream reaction in the cell, leading to the 
morphology changes [2]. Soluble factors such as hormones 
and cytokines can distribute from the donor cells to the 
cognate receptors on the membrane surface after transmitting 
to the target cells [3]. Gap junction, which is analogs to 
plasmodesmata in plants, plays essential roles in the 
formation of separate cellular compartments for specific 
differentiation processes in animals [1]. Induced development 
in the morphogenesis of early organ development is a 
phenomenon based on typical cell communication that 
involves neighboring cells recognizing and coordinating 
with each other, which is manifested in the mesenchyme to 
epithelial transition induced by the interaction between the 
ureteric bud and mesenchyme during embryo kidney 
development [4,5]. Additionally, cell communication is 
essential for innate and acquired immunity to balance the 
stimuli and cytokine molecule expression [6], and failure in 
cell communication mediated by gap junction results in 
unrestrained proliferation of tumor cells [7]. Hormones, 
cytokines, cAMP, Ca2+, and even nitric oxide (NO), carbon 
monoxide (CO) can be message transmitters causing 
physiological and pharmacological effects between cells 
and even tissues. Hence, it is intriguing to learn whether 
other message mediators are invovled in cell communi- 
cation.  
Genetic materials can move between different cells, 
implying that nucleic acid could be one component of 
various messengers for cell communication. Early in 1977, 
circulating cell free DNA (CFDNA) [8], which binds to the 
nucleoprotein to increase its stability, was discovered in the 
plasma of cancer patients [9]. To some extent, CFDNA 
operates as an indicator of cancer onset, and is actively 
released from the cell [10]. In addition, RNA molecules, 
including mRNA and miRNA, are shuttled between 
different mast cells and the moving mRNA can be 
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translated into new proteins in recipient cells [11], which 
demonstrates that the information transmitted by RNA is 
intact and functional. There are some unique characteristics 
about moving RNAs compared with traditional cell 
communication. Moving RNAs are usually packaged in the 
vesicles to drift the expression profile of target cells. 
Furthermore, moving RNAs may directly enter the nucleus 
to dynamically remodel the chromatin status and regulate 
gene expression epigenetically. In this review, we summarize 
that moving RNA executes as a messenger for intercellular 
communication and plays a crucial function in cell 
physiology and tumor development. 
1  RNA molecule serves as a messenger 
Generally, RNAs can be categorized into protein coding 
messenger RNAs (mRNAs) and non-coding RNAs 
(ncRNAs). mRNAs transcribed in the nucleus are sequen- 
tially organized in triplet genetic codons for specific amino 
acids and transported to the cytoplasm for protein 
translation. ncRNAs such as miRNA, piRNA, snoRNA, and 
lncRNA are considered as not being translated into proteins 
and act as regulators in gene expression through various 
mechanisms. 
RNA molecules composed of nucleotides A, U, G, and C 
are conventionally considered to be the message trans- 
mitters between genetic DNA and variable proteins 
according to the central dogma. However, the genetic 
materials of retrovirus are RNA, illustrating that the 
function of RNA is far greater than protein coding. Besides, 
the morphology change mediated by RNA is stable and can 
be passed on to the next generation. In 1977, by injectting 
mRNA from mature eggs of crucian into fertilized eggs of 
goldfish, Tung [12] showed that exogenous mRNA can 
change the tail shape, and this new trait can be transmitted 
to the offspring. Forty or so years later, Gu et al. [13] 
injected siRNA into Caenorhabditis elegans, which 
triggered the increase of H3K9me3 on its target gene and 
was inherited by the progeny for at least two generations, 
suggesting that the modulating effects created by RNA can 
be maintained through numerous generations. All these 
artificial effects inspire us to believe that in natural 
circumstances, moving RNA will enter the recipient cells 
and function beyond our expectation. 
Oral gavage of mice with TNF- siRNA particles can 
decrease the level of TNF- in the organs of the mice, 
which provides a new strategy for oral delivery of siRNA to 
attenuate inflammatory responses in human diseases [14]. 
Recent reports showed that RNA moves in the cell exterior 
and serves as a messenger molecule between cells. 
Specifically, miR-214 [15] and miR-133b [16] can move 
through microvesicles. Similarly, about 1300 transcripts 
released from the MC/9 cell can enter recipient cells with 
the microvesicle’s assistance [11]. In plants, siRNAs can be 
imparted from the shoot to the root through the plasmo-     
desmata [17]. Evidentally, RNA can function as a type of 
messengers between cells.  
2  The intra and inter species movement of 
RNA  
The movement of RNA among cells will take effect as a 
long-range regulatory molecule that orchestrates the 
behaviors of different cell types in response to external 
stimuli.  
RNAi was found to block gene expression in eukaryotic 
organisms [18], which can cross cellular boundaries and 
spread between cells and tissues in C. elegans and plants 
[19,20]. It was found in 1998 that Escherichia coli 
expressing a dsRNA segment from unc-22 gene can confer 
interference effects on the C. elegans fed by E. coli [21]. 
Not only in C. elegans, it was first reported in 2006 that 
mRNAs from murine ES cells are transferable to other cells 
for translating into the corresponding proteins in recipient 
cells and may be functional in this new location [22]. In 
2010, miR-150 in the exosome was demonstrated to be 
selectively released from THP-1 cells and moves into 
human HMEC-1 cells to enhance recipient cell migration, 
which denotes that the moving miR-150 can be a long-range 
regulator of gene expression in recipient cells [23]. In 2010, 
it was proved that transgene-derived small 24 nt RNA 
moved across the graft union to silence the root GFP signal 
through epigenetic modifications, which conspicuously 
validated that moving RNA can transfer silencing signals 
between different parts of the Arabidopsis thaliana [17]. 
The movement of small RNA in plants is unprecedentedly 
demonstrated by the obsevation of GFP decrease. More 
recent studies have demonstrated that moving RNA can 
serve as a new class of biomarkers for diseases, such as 
tumors and immune diseases [24,25]. 
Moving RNAs widely exist in the biological world and 
satisfy the genetic information exchange between different 
cells [26], which can regulate physiological and patho-      
logical processes. Intercellular communication is essential 
to coordinating cellular activity in multicellular organisms 
and it is stirring to find that RNA can be a cellular 
messenger. Henceforth, it is fascinating to explore why and 
how the moving RNA is able to move out of the cell and 
what mechanism is responsible for the packaging of moving 
RNAs.  
3  The RNA territory directs RNA moving  
It has long been acknowledged that cellular contents can be 
delivered during neurotransmission processes. The release 
is regulated by a voltage-dependent calcium channel and the 
vesicles are essential for propagating nerve impulses between 
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neurons [27,28], so the small RNAs can be transported 
extracellularly in vesicles or through special channels. The 
RNAs and proteins can be delivered to the border of the 
intracellular membrane, then a contractile ring will be 
formed and the cytoskeleton will be reorganized and the 
membrane components will be deallocated. RNAs and 
proteins can also be wrapped in the degradative vesicles and 
discharged into the recipient cells via the vesicle and cell 
membrane fusion [29,30].  
The non-random arrangement of nuclear architecture 
proposed by Carl Rabl in the 19th century exhibits that 
chromosomes are compartmentalized into discrete territories 
to regulate transcription and splicing [31–33]. A typical 
characteristic of stem cells, such as intestinal stem cells and 
neural stem cells, is that they are asymmetrically divided, 
which is influenced by cell polarity [34,35]. Interestingly, 
the subcellular distribution of RNA, which requires specific 
RNA-binding proteins to interact with RNA-transport 
sequences in mRNA, aids the establishment of cell polarity 
[36,37]. The RNA transcript prearranged localization, RNA 
territory, is linked to polarized cells [38,39]. Meiosis in 
oogonia generates one oocyte and three polar bodies [40]. In 
starfish, the copy number of RNA transcripts in the oocyte 
is 25–16000 folds higher than the sibling polarized bodies 
[41], which supports that RNA distribution influences 
asymmetrical division of the oocyte in meiosis. In somatic 
cells, mouse miR-709 is predominantly located in the 
nucleus and the localization pattern will rapidly change 
upon apoptotic stimuli [42], which provides further evid- 
ence for RNA localization’s imperative effect on RNA 
moving. 
4  MVs: vital carriers of RNA moving 
The cellular heterogenous distribution of the RNA molecule 
implies that RNA can be mobile between cells. The 
microvesicle (MV) is a paramount carrier for RNA moving 
(Figure 1A). Morphologically, MVs are microparticles 
secreted from cells. Exosomes and shedding vesicles (SVs) 
are two types of MVs with distinct biogenesis pathways. 
The diameter of exosomes (30–100 nm) is smaller than that 
of shedding vesicles (100–1000 nm) [43]. The components 
within the MV inclusion and the membrane itself are  
 
 
Figure 1  The biogenesis and imminent role of moving RNAs. A, Generation and release of moving RNA. The blue ellipse represents the donor cell of 
moving RNA and the red square represents the neighbor cells. Exosome and shedding vesicles are two forms of microvesicles (MVs). Exosomes are derived 
from multivesicular bodies (MVBs). Shedding vesicles are generated by the budding of the cell plasma membrane. Nanotubes and directly binding with 
specific proteins are possible ways of moving RNA release. B, The imminent role of moving RNA in the recipient cells. MVs can be uptaken by fusion with 
the cell membrane or endocytosis by recipient cells. Moving miRNAs from donor cells can target on the 3′UTR of mRNA or promoter in recipient cells to 
regulate gene expression. mRNAs can also move into recipient cells to translate into the corresponding proteins. C, Morphology of recipient cells drift to the 
donor cells. Specific moving miRNAs from metastatic tumor cells “assimilate” neighbor cells co-localized with the tumor colony. 
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dependent on both the MV biogenesis and the donnor cells. 
Some proteins on MVs’ membrane are cell specific while 
others are “housekeeping” among the majority of MVs, 
such as Hsp70 and Tetraspan protein [44,45]. 
Exosomes are derived from the intraluminal vesicles 
within multivesicular bodies (MVBs) of the late-endosome, 
which can package moving RNA and specific proteins 
[46,47]. Hence, the biochemical characteristics of exosomes 
are analogous to the vesicles of MVBs. MVBs are 
associated with P-bodies, where miRNA may function 
through GW182 and AGO2 [48]. GW182 is sorted into 
MVBs via endosomal sorting complex required for trans-      
port (ESCRT) component, suggesting that MVBs may be 
the sites of miRNAs, miRNA-repressible mRNAs and RISC 
accumulation and action [49]. Exosome release is triggered 
by ceramide [50], which is synthesized with NSMase2 
(neutral sphingomyelinase). Then, the MVBs will fuse with 
the cell membrane and the exosome will be secreted into the 
extracellular fluid [51]. 
Shedding vesicles, or microparticles, are generated by the 
budding of the cell plasma membrane [43]. The release of 
shedding vesicles depends on the alteration of the Ca2+ level 
in the cell. Once the Ca2+ level in the cell reaches the 
threshold, it will elicit the rearrangement of enzymes on the 
cell membrane and the reorganization of cytoskeleton, 
leading to the extrication of the shedding vesicle to the cell 
exterior [52]. 
Under common physiological and pathological circums-     
tances, MVs can be produced in almost all cells. Recently, 
miRNAs have been discovered to be a component of MVs 
[23,53], which signifies that the organism circulation flux 
can assist cellular miRNAs to arrive at recipient cells and to 
function properly once they have arrived.  
5  Detection of RNA moving 
The specific protein markers on the membrane of exosomes, 
such as Alix, TSG101 and HSP70, allow them to be 
distinguished from cell debris, which can be used to detect 
the microvesicles packaged with moving RNA [54]. 
(i) MVs can be stained with Lipotropy fluorescent dyes 
such as DiI-C18, and the structure of tinted MVs can be 
observed using an electron microscope or fluorescence 
microscope [55]. 
(ii)  The MV donor cells can be exposed to the medium 
containing nucleotides labeled with isotope and the RNAs 
in MVs can be detected by autoradiography [11]. 
(iii)  The mutant or Cy3-labeled pre-miRNAs can be 
transfected into the MV donor cells, which are then 
cocultured with the recipient cells. This allows the mutant 
or Cy3-labeled miRNA that is different from the 
endogenous miRNA to be detected in the donor cells as well 
as the recipient cells [56,57]. 
6  The imminent role of moving RNA in reci- 
pient cells 
Under physiological and pathological conditions, tissues or 
cells can secrete and release MVs into the blood, lymph, 
cerebrospinal fluid, and other body fluids. The secretory 
vesicle may fuse with the target membrane through a 
manner known as kiss-and-run (KR), in which the vesicle 
releases intravesicular contents through a temporary, nano-     
meter-sized fusion pore while retaining the gross morpho- 
logical shape [58,59]. In Drosophila cells, dsRNA entry is 
an active process involving endocytosis, which is mediated 
by pattern-recognition receptors [60]. The moving miRNA 
that enters the recipient cell will adapt to the intracellular 
homeostasis and function on the target mRNA with various 
mechanisms (Figure 1B). 
6.1  Gene silencing through 3′UTR  
The cannonical function of miRNA is to induce the 
degradation or translation repression by targeting on the 
3′UTR of mRNA. 
The monocytic miR-150 moves to the recipient HMEC-1 
cell and targets on the 3′UTR of c-Myb mRNA, which leads 
to a significant reduction of the c-Myb protein level in the 
HMEC-1 cell. c-Myb is critical to various cellular functions, 
including proliferation, differentiation and migration. There- 
fore, the decrease of c-Myb enhances the migration of the 
recipient HMEC-1 cell [23].  
KLF2 determines endothelial specific gene expression 
patterns induced by atheroprotective flow. In KLF2/ mice, 
an apparently normal endothelium was exhibited, while 
smooth muscle cells (SMCs) were dysfunctional and 
disorganized, implying that an important communication 
exists between the KLF2 expressing endothelium and the 
underlying SMC. The moving miR-143/145 in extracellular 
vesicles secreted from KLF2-expressing endothelial cells 
can regulate ELK1 and KLF4 expression in the co-cultured 
SMCs, which pinpoints that moving miRNA in extracellular 
vesicles may be involved in the communication between 
endothelial cells and SMCs and the blockage of this 
communication may encompass a promising strategy to 
combat atherosclerosis [61]. 
6.2  Transcription activation through targeting on the 
promoter  
miRNA is not only able to downregulate translation but also 
potentially upregulate gene’s expression by targeting on the 
promoter. MiR-373 can target on the promoter of 
E-cadherin and enhance its expression with the help of 
Dicer. MiR-373 also induces the expression of CSDC2 in the 
same manner as E-cadherin. Moreover, RNA polymerase II 
was erected to be enriched on the promoter of E-cadherin 
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and CSDC2 after miR-373 transfection [62]. Deductively, 
we believe that moving RNA can also function in a similar 
way in recipient cells. 
7  Moving RNA as a biomarker 
Moving RNA has been characterized in the course of 
atherosclerosis and cancers [63,64], which is a promising 
early diagnostic biomarker [65]. Moving miRNA holds high 
stability in the plasma and miRNA detection is much more 
implementable and economical than the current screening 
procedures.  
The expression profile of moving miRNA is aberrant in 
specific cancer patients. The high level of moving miR-221 
is correlated with the tumor progression of hepatocellular 
carcinoma (HCC) [66], which is a prognostic sign of HCC 
treatment. In addition, since miR-155 is overexpressed and 
detectable in the plasma in chronic lymphocytic leukemia 
(CLL) patients, it is a marker used to note that CLL patients 
are in fact responding towards therapy [67]. Moving miRNA 
is also involved in cardiovascular system diseases. The level 
of moving miR-133a in patients with cardiovascular diseases 
is increased, which may be a biomarker for cardiovascular 
diseases [68]. 
8  Moving RNA and tumor metastasis 
The expression of miRNA has a strong tissue-specificity in 
mammals. 
MiR-124 is preferentially expressed in the brain, which is 
proved to promote neuronogenesis progression. MiR-124 
delivered to the HeLa cells can drift the expression profile 
towards that of the brain [69]. The powerful function of 
tissue-specific miRNA prompts us to wonder whether 
moving RNA can change the behavior of recipient cells. 
Tumor metastasis to distant organ sites usually leads to 
the failure of cancer treatment and 90% of cancer patients 
have died of tumor metastasis. Interaction between 
metastasized tumor cells and cells co-localized with the 
tumor colony could establish the tumor-favoring micro-     
environment, which is believed to be one of the most 
critical steps during tumor metastasis [65,70]. As miRNA 
and mRNA can be shuttled between different cells, moving 
miRNA undoubtedly plays an important role in tumor 
metastasis [57]. The tumor cells can actively secret or 
release miRNA in extracellular fluids in the form of MVs 
[71], which can “assimilate” neighboring cells [57,72] that 
are co-localized with the tumor colony (Figure 1C). These 
moving RNAs can transfer the message from tumor cells 
into new target neighbors [73], leading to the epigenetic 
modification of the recipient cells and forming a suitable 
microen-vironment for ectopic tumor proliferation. Thus, 
moving miRNA is a new messenger of cell communication 
and contributes to cancer metastasis. This may provide a 
new strategy for early diagnosis and treatment of metastatic 
cancer [74]. 
9  Moving RNA moves the biological world at 
large  
In essense, extracellular RNA originates from cytoplasmic 
and nuclear RNA, and its biological function may be more 
significant in the biological world than our callow 
expectations.  
9.1  The messenger in the biological chain 
The moving RNA is not only capable of shuttling among 
cells within the same species but can also take genetic 
materials from one species to another and may regulate 
“inter-species” cellular functions [75]. Information exchange 
is essential for the maintenance of the biological chain among 
different species. Endogenous non-coding RNA of E. coli, 
OxyS and DsrA, can downregulate the che-2 and F42G9.6 
genes to decrease the longevity of C. elegans [76]. The 
existence of the rice miR-168a in human plasma and the 
potential modulations on human gene expression imply that 
moving RNA participates in the biological cycle [77]. In 
these cases, a lower organism can transport information and 
alter the gene expression profile in a higher organism 
through moving RNAs that carry specific instructions. Thus, 
all organisms that take part in the biological chain learn to 
adapt to each other and form a harmonious, stabilized 
biosphere.  
These data pinpoint that the moving miRNA can act in a 
cross-kingdom pattern, which provides an original course to 
explore miRNA-mediated interactions among food chain 
species. 
9.2  The “language” within embryonic organogenesis 
Cell communication, which is both spatial and temporal, 
may be engaged in the early development of different 
embryonic layers [78,79]. More specifically, moving RNAs 
are the elements of the language required for this communi-   
cation. The direct evidence is that moving miR-512-3p, 
miR-516b-5p and miR-517-3p transfected from the cultured 
placental trophoblasts are capable of transferring the ability 
to resist against virus infections to other non-placental cells 
[80]. 
9.3  The new actors of the immune system 
The immune system is the defense barrier against invasions 
of viruses or bacteria by secreting a large number of 
biomolecules to the infected site, in particular, moving 
RNAs take part in this process by performing as the new 
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actors during immune defense [81]. miR-150 released from 
the human monocytic THP-1 cell line can enhance the 
migration of endothelial cells, pointing out the possibility 
that actively released miRNA from immune cells may target 
on the viruses or bacteria, and work as an element of 
immune machinery [23]. 
9.4  The message transmitters in nervous impulse 
The neurotransmitters are essential messengers in the 
chemical synaptic transmission, and moving RNAs can act 
as new message carriers in nervous impulse. miR-133b can 
move from mesenchymal stromal cells to brain parenchymal 
cells via exosomes, and moving miR-133b could alter the 
target neural cells outgrowth [82]. Hence, perhaps moving 
miRNA in vesicles released by nervous cells is a type of 
message transmitters that await further investigation and 
validation.  
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